Abstract
Absent compelling indications such ashypercalcemia or cardiac involvement, the decision to inter-vene withcorticosteroidtherapy (CST)typically ariseswithinthefirsttwoyearsoutofconcernthatthisoutcomemayensuein persons with unresolving pulmonary shadowing.Izumi, in a seminal case-control study of largelyasymptomatic, predominantly stage I sarcoidosis, observeda marked adverse effect of elective CST.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
